KURA ▲ +0.9% - Kura Oncology, Inc. $KURA - Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes Kura Oncology rose 0.9% after announcing the launch of Caspian Therapeutics, a new company focused on menin inhibition for diabetes treatment, backed by $50 million in financing. The spinout represents Kura's expansion into metabolic disease beyond its current oncology focus, potentially opening a new revenue stream through a disease-modifying therapeutic approach. 09-SEP-2026 07:00 AM ET